Status:
COMPLETED
Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
An efficacy and safety study of ezetimibe (+) simvastatin compared to atorvastatin at week 6 in diabetics or metabolic syndrome patients in Korea.
Eligibility Criteria
Inclusion
- Clinical diagnosis of hypercholesterolemia
- Drug naive or statin treated but inadequately controlled patients against NCEP ATP III guideline goal
Exclusion
- Hypersensitivity to HMG-CoA inhibitor or Ezetimibe
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT00157924
Start Date
November 1 2005
End Date
September 1 2007
Last Update
June 7 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.